Next earnings date: 27 Oct 2025
Stryker Corporation – LSE:0R2S.L
Stryker stock price today
Stryker stock price monthly change
Stryker stock price quarterly change
Stryker stock price yearly change
Stryker key metrics
Market Cap | 138.97B |
Enterprise value | 151.58B |
P/E | 38.97 |
EV/Sales | 6.89 |
EV/EBITDA | 27.65 |
Price/Sales | 6.36 |
Price/Book | 6.94 |
PEG ratio | -1.69 |
EPS | 8.84 |
Revenue | 20.96B |
EBITDA | 5.19B |
Income | 3.36B |
Revenue Q/Q | 9.73% |
Revenue Y/Y | 10.61% |
Profit margin | 16.34% |
Oper. margin | 20.37% |
Gross margin | 62.47% |
EBIT margin | 20.37% |
EBITDA margin | 24.79% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeStryker stock price history
Stryker stock forecast
Stryker financial statements
| Jun 2023 | 4.99B | 738M | 14.77% |
|---|---|---|---|
| Sep 2023 | 4.90B | 692M | 14.1% |
| Dec 2023 | 5.81B | 1.14B | 19.66% |
| Mar 2024 | 5.24B | 788M | 15.03% |
| Sep 2025 | 5.73B | 1.21B | 21.17% |
|---|---|---|---|
| Dec 2025 | 6.81B | 1.58B | 23.26% |
| Mar 2026 | 5.81B | 1.17B | 20.21% |
| Mar 2026 | 6.08B | 1.22B | 20.15% |
Analysts Price target
Financials & Ratios estimates
| 2024-10-29 | 2.77 | 2.16 |
|---|
| Payout ratio | 33.4% |
|---|
| 2019 | 0.99% |
|---|---|
| 2020 | 0.94% |
| 2021 | 0.94% |
| 2022 | 1.14% |
| 2023 | 1% |
| Jun 2023 | 37409000000 | 20.04B | 53.59% |
|---|---|---|---|
| Sep 2023 | 38042000000 | 20.13B | 52.93% |
| Dec 2023 | 39912000000 | 21.31B | 53.42% |
| Mar 2024 | 39402000000 | 20.23B | 51.34% |
| Jun 2023 | 688M | -533M | -405M |
|---|---|---|---|
| Sep 2023 | 1.05B | -145M | -422M |
| Dec 2023 | 1.52B | -152M | -286M |
| Mar 2024 | 204M | -408M | -418M |
Stryker alternative data
| Aug 2023 | 51,000 |
|---|---|
| Sep 2023 | 51,000 |
| Oct 2023 | 51,000 |
| Nov 2023 | 51,000 |
| Dec 2023 | 51,000 |
| Jan 2024 | 51,000 |
| Feb 2024 | 51,000 |
| Mar 2024 | 52,000 |
| Apr 2024 | 52,000 |
| May 2024 | 52,000 |
| Jun 2024 | 52,000 |
| Jul 2024 | 52,000 |
Stryker other data
| Insider | Compensation |
|---|---|
| Mr. Kevin A. Lobo (1965) Chairman & Chief Executive Officer | $4,370,000 |
| Mr. Timothy J. Scannell (1965) Pres & Chief Operating Officer | $2,060,000 |
| Mr. Glenn S. Boehnlein (1962) Vice President & Chief Financial Officer | $1,650,000 |
| Mr. Viju S. Menon (1968) Group Pres of Global Quality & Operations | $1,260,000 |
Mr. Robert S. Fletcher (1971) Vice President & Chief Legal Officer | $831,180 |
| Ms. M. Kathryn Fink Vice President & Chief HR Officer | |
Ms. Bronwen R. Taylor Vice President of Compliance & Risk Management | |
Mr. Preston Wells Vice President of Investor Relations | |
| Ms. Yin C. Becker Vice President of Communications, Public Affairs & Corporation Marketing | |
Mr. Robert C. Cohen Chief Technology Officer and Vice President of Global R&D - Joint Replacement |
-
What's the price of Stryker stock today?
One share of Stryker stock can currently be purchased for approximately $267.98.
-
When is Stryker's next earnings date?
Stryker Corporation is estimated to report earnings on Monday, 27 Oct 2025.
-
Does Stryker pay dividends?
Yes, Stryker pays dividends and its trailing 12-month yield is 0.65% with 33% payout ratio. The last Stryker stock dividend of $0.58 was paid on 31 Jul 2020.
-
How much money does Stryker make?
Stryker has a market capitalization of 138.97B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 11.11% to 20.5B US dollars. Stryker earned 3.17B US dollars in net income (profit) last year or $2.16 on an earnings per share basis.
-
What is Stryker's stock symbol?
Stryker Corporation is traded on the LSE under the ticker symbol "0R2S.L".
-
What is Stryker's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Stryker?
Shares of Stryker can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Stryker's key executives?
Stryker's management team includes the following people:
- Mr. Kevin A. Lobo Chairman & Chief Executive Officer(age: 60, pay: $4,370,000)
- Mr. Timothy J. Scannell Pres & Chief Operating Officer(age: 60, pay: $2,060,000)
- Mr. Glenn S. Boehnlein Vice President & Chief Financial Officer(age: 63, pay: $1,650,000)
- Mr. Viju S. Menon Group Pres of Global Quality & Operations(age: 57, pay: $1,260,000)
- Mr. Robert S. Fletcher Vice President & Chief Legal Officer(age: 54, pay: $831,180)
- Ms. M. Kathryn Fink Vice President & Chief HR Officer
- Ms. Bronwen R. Taylor Vice President of Compliance & Risk Management
- Mr. Preston Wells Vice President of Investor Relations
- Ms. Yin C. Becker Vice President of Communications, Public Affairs & Corporation Marketing
- Mr. Robert C. Cohen Chief Technology Officer and Vice President of Global R&D - Joint Replacement
-
How many employees does Stryker have?
As Jul 2024, Stryker employs 52,000 workers.
-
When Stryker went public?
Stryker Corporation is publicly traded company for more then 10 years since IPO on 6 Nov 2014.
-
What is Stryker's official website?
The official website for Stryker is stryker.com.
-
Where are Stryker's headquarters?
Stryker is headquartered at 2825 Airview Boulevard, Kalamazoo, MI.
-
How can i contact Stryker?
Stryker's mailing address is 2825 Airview Boulevard, Kalamazoo, MI and company can be reached via phone at +269 385 26 00.
Stryker company profile:
Stryker Corporation
stryker.comLSE
52,000
Medical - Equipment & Services
Healthcare
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Kalamazoo, MI 49002
:
ISIN: US8636671013
:
